Course Curriculum

This medical examiner training course conforms to the Federal Motor Carrier Safety Administration’s(FMCSA) training curriculum modules and topics on regulations and guidelines for conducting CMV driver medical examinations. FMCSA regulations and guidelines are reviewed regularly, and the training is updated as required. This course was last updated on 01/15/2012.
Course content meets or exceeds the eight topics outlined in FMCSA’s current core curriculum specification.

The Ease of Our Online NRCME DOT Medical Examiner Training

  • Provides the maximum flexibility and efficiency to take the course where and when you want. NADME.org is NOW AVAILABLE on your iPad or favorite tablet for on-the-go training!
  • Enables you to take the course at your own pace over an extended time period. Log in and out as time permits! No travel or other related expenses necessary.
  • Documents your individual progress, including attendance and test scores.
  • Each paid registration comes with a FREE 1 year subscription to log back in to the course and review materials prior to testing.

What Can Our NRCME DOT Medical Examiner Course Do for You?

  • New DOT NRCME regulations provide a new market opportunity for your practice.
  • Provides a comprehensive, practical explanation of the federal DOT driver medical examination regulatory requirements governing driver physical examinations.
  • Meets the requirements of the DOT NRCME for certification training.
  • Improves the overall thoroughness and quality of the DOT NRCME driver physical examination, thereby helping to ensure driver health, reduce accidents, and save lives.

Course Modules

Module 1 – General FMCSA Information

Part I – General FMCSA Information

  • FMCSA Mission Statement
  • FMCSA: Dedicated to Safety
  • Who Can Be a Medical Examiner?
  • When Is Medical Certification Required?
  • Important Definitions
  • Privacy and the Medical Examination
  • Medical Regulations Summary

Part II – The Job of Commercial Driving

  • FMCSA Regulates Interstate Commercial Operation
  • The Driver and Driver Role
  • FMCSA Commercial Driving Facts and Research
Module 2 – Medical Examiner Guidelines

Part III – Medical Examination GuidelinesAbout 49 CFR 391.43

  • Driver/Medical Examiner Relationship
  • Medical Examination Report Form – Overview
    • Medical Examination Report Form (PDF)
    • Driver Information
    • Health History
    • Vision
    • Hearing
    • Blood Pressure/Pulse
    • Urinalysis
    • Physical Examination
    • Determine Certification Status
    • Certify
    • Disqualify
    • Issue Medical Examiner’s Certificate
Module 3 – Physical Qualification Standards
 Vision/Hearing

Part IV – Guidance/Advisory Criteria

  • About 49 CFR 391.41
  • Vision 49 CFR 391.41(b)(10)
    • Ophthalmic Preparations
    • Vision Tests
    • Ophthalmic Diseases
    • Federal Vision Exemption Program
  • Hearing 49 CFR 391.41(b)(11)
    • Otic Preparations
    • Hearing Tests
    • Otic Disease and Conditions
Module 4 – Hypertension

Hypertension (b)(6)

Measure Blood Pressure & Check Pulse

  • Essential Hypertension
  • Stage 1 Hypertension
  • Stage 2 Hypertension
  • Stage 3 Hypertension
  • Secondary Hypertension
Module 5 – Cardiovascular

Cardiovascular (b)(4)

  • Anticoagulant Therapy (content links)
  • Cardiovascular Tables Archive
    • Aneurysms, Peripheral Vascular Disease, and Venous Disease and Treatments
    • Abdominal Aortic Aneurysm
    • Acute Deep Vein Thrombosis
    • Chronic Thrombotic Venous Disease
    • Intermittent Claudication
    • Other Aneurysms
    • Peripheral Vascular Disease
    • Post-Surgical Repair of Aneurysm
    • Pulmonary Emboli
    • Superficial Phlebitis
    • Thoracic Aneurysm
    • Varicose Veins
  • Cardiac Arrhythmias and Treatments
    • Implantable Cardioverter-Defibrillators
    • Pacemakers
    • Supraventricular Arrhythmias
    • Ventricular Arrhythmias
  • Cardiovascular Tests
    • Echocardiography
    • Exercise Tolerance Test
  • Cardiovascular Recommendation Tables Available in PDF
  • Coronary Heart Diseases and Treatments
    • Acute Myocardial Infarction
    • Angina Pectoris
    • CHD Risk-Equivalent — Multiple CHD Risk Factors
    • Coronary Artery Bypass Grafting
    • Heart Failure
    • Percutaneous Coronary Intervention
  • Congenital Heart Disease
    • Ebstein Anomaly
  • Heart Transplantation
  • Hypertension (b)(6)
    • Measure Blood Pressure & Check Pulse
    • Essential Hypertension
      • Stage 1 Hypertension
      • Stage 2 Hypertension
      • Stage 3 Hypertension
    • Secondary Hypertension
  • Myocardial Disease
    • Hypertrophic Cardiomyopathy
    • Restrictive Cardiomyopathy
  • Syncope
  • Valvular Heart Diseases and Treatments
    • Aortic Regurgitation
    • Aortic Stenosis
    • Aortic Valve Repair
    • Mitral Regurgitation
    • Mitral Stenosis
    • Mitral Stenosis Treatment
    • Mitral Valve Prolapse
    • Mitral Valve Repair for Mitral Regurgitation
    • Prosthetic Valves
    • Pulmonary Valve Stenosis
Module 6 – Respiratory

Respiratory (b)(5)

  • Antihistamine Therapy
  • Allergies and Asthma-related Diseases
    • Allergic Rhinitis
    • Allergy-related Life-threatening Conditions
    • Asthma
    • Hypersensitivity Pneumonitis
  • Chronic Obstructive Pulmonary Disease
  • Chronic Sleep Disorders
  • Infectious Respiratory Diseases
    • Acute Infectious Diseases
    • Atypical Tuberculosis
    • Pulmonary Tuberculosis
  • Non-infectious Respiratory Diseases
    • Chest Wall Deformities
    • Chronic Obstructive Pulmonary Disease
    • Cystic Fibrosis
    • Interstitial Lung Disease
    • Pneumothorax
  • Pulmonary Function Tests
  • Secondary Respiratory Conditions and Underlying Disorders
    • Chronic Sleep Disorders
    • Cor Pulmonale
    • Pulmonary Hypertension
    • Sleep Disorder Tests
Module 7 – Neurological

Neurological (b)(7)(8)(9)

  • Anticoagulant Therapy (content links)
  • Anticonvulsant Therapy
  • Episodic Neurological Conditions
    • Acute Seizures — Structural Insult to the Brain
    • Acute Seizures — Systemic Metabolic Illness
    • Childhood Febrile Seizures
    • Epilepsy
    • Headaches
    • Single Unprovoked Seizure
    • Vertigo and Dizziness
  • Infections of the Central Nervous System
  • Neuromuscular Diseases
    • Autonomic Neuropathy
    • Conditions Associated with Abnormal Muscle Activity
    • Congenital Myopathies
    • Metabolic Muscle Diseases
    • Motor Neuron Diseases
    • Muscular Dystrophies
    • Neuromuscular Junction Disorders
    • Peripheral Neuropathies
  • Progressive Neurological Conditions
    • Central Nervous System Tumors
    • Dementia
  • Static Neurological Conditions
    • Embolic and Thrombotic Strokes
    • Intracerebral and Subarachnoid Hemorrhages
    • Transient Ischemic Attack
    • Traumatic Brain Injury
  • Summary of Neurological Waiting Periods
Module 8 – Musculoskeletal

Musculoskeletal (b)(1)(2)(7)

  • Skill Performance Evaluation — 49 CFR 391.49
    • Fixed Deficit of an Extremity
  • Musculoskeletal Tests
    • Grip Strength Tests
  • Neuromuscular Diseases
    • Autonomic Neuropathy
    • Conditions Associated with Abnormal Muscle Activity
    • Congenital Myopathies
    • Metabolic Muscle Diseases
    • Motor Neuron Diseases
    • Muscular Dystrophies
    • Neuromuscular Junction Disorders
    • Peripheral Neuropathies
Module 9 – Diabetes Mellitus

Diabetes Mellitus (b)(3)

  • Diabetes Mellitus
  • Federal Diabetes Exemption Program
  • Incretin Mimetic
  • Insulin Therapy
  • Non-Insulin Medications
Module 10 – Other Diseases

Other Diseases (b)(9)

  • Hernia
  • Nephropathy
  • Urinalysis
Module 11 – Psychological Disorders

Psychological Disorders (b)(9)

  • Antidepressant Therapy (content links)
  • Antipsychotic Therapy(content links)
  • Anxiolytic and Sedative Hypnotic Therapy (content links)
  • Central Nervous System Stimulant Therapy (content links)
  • Electroconvulsive Therapy (content links)
  • Lithium Therapy (content links)
  • Adult Attention Deficit Hyperactivity Disorder
  • Bipolar Mood Disorder
  • Major Depression
  • Personality Disorders
  • Schizophrenia and Related Psychotic Disorders
Module 12 – Drug Abuse and Alcoholism

Drug Abuse and Alcoholism(b)(12)(13)

  • About 49 CFR 382 Alcohol and Drug Rules
  • Alcoholism
  • Drug Abuse
Module 13 – Medications and Drug Use

Medications/Drug Use 49 CFR 391.41(b)(12)

  • About 21 USC Sec. 812 Schedules of Controlled Substances
Module 14 – Medical Examination Report Form Summary

Medical Examination Report Form Summary

  • Medical Examination Report Form – Page 1
  • Medical Examination Report Form – Page 2
  • Medical Examination Report Form – Page 3

Course Includes

  • 14 hours of comprehensive instruction
  • 14 quizzes - 100 question final exam
  • 43 clinical practice scenarios
  • Unlimited review of modules
  • Certificate of completion
  • 1 full year access to course
  • All course downloads and materials
  • Individual registration price: $595
  • Call for group rates: 855-695-0688

Print Course Brochure

Why NADME?

  • NADME exceeds the NRCME core curriculum requirements
  • NADME is listed with the DOT-NRCME as a training provider
  • Approved for AMA-PRA Category 1 Credits™ for up to 18 hours
  • Completely delivered online
  • Self-paced study - anywhere you're connected
  • No scheduled webinars to attend